News
Experts warn new FDA COVID vaccine policy overlooks long-term risks
The Food and Drug Administration is changing how it handles COVID-19 vaccines starting this fall, limiting access to older adults and those with certain medical conditions. But some health experts said the move could leave too many people at risk.
Trump admin's new FDA update limits annual COVID shots to high-risk groups, ending routine access for healthy kids and adults ...
The US Food and Drug Administration will now require Covid-19 vaccines from Pfizer/BioNTech and Moderna to use expanded ...
The notice came shortly after an advisory panel meeting at which members debated the pros and cons of asking manufacturers to ...
Agency will ask drugmakers for large trials for new versions of vaccines meant for healthy adults and children.
Federal health officials will no longer routinely approve annual COVID-19 shots for younger adults and children who are ...
After a six-week delay, the US Food and Drug Administration has approved Novavax’s Covid-19 vaccine, according to a letter ...
U.S. Food and Drug Administration advisers unanimously recommended on Thursday that COVID-19 vaccines for the 2025-26 period ...
Government vaccine advisers are meeting to decide if the recipe for COVID-19 vaccines needs updating for this fall and winter ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback